New oral anticoagulants (NOACs) vs. warfarin: Are doctors ready to switch?

被引：0
|
作者：
Ahmed, Mahin [1 ]
Gautam, Manish [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Resp Med, Liverpool, Merseyside, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Education; Embolism; Pharmacology;
D O I：
10.1183/13993003.congress-2015.PA2779
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2779
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Stroke Incidence Among Atrial Fibrillation Patients Taking Novel Oral Anticoagulants (noacs) Compared to Warfarin
    Shpak, Max
    Nadasdy, Zoltan
    Cowperthwaite, Matthew
    Ramakrishnan, Anurekha
    Orndorff, Kevin
    Fanale, Christopher V.
    STROKE, 2018, 49
  • [42] Comparison of serious adverse events in very elderly Asian atrial fibrillation patients with or without anticoagulation therapy: direct oral anticoagulants vs. warfarin vs. non-anticoagulants
    Sakamoto, A.
    Okawa, K.
    Hara, S.
    Taya, S.
    Sudo, Y.
    Sogo, M.
    Ugawa, S.
    Okada, T.
    Nosaka, K.
    Takahashi, M.
    Sakane, K.
    Doi, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 486 - 486
  • [43] Stroke Risk with Warfarin vs. NOACs in Artificial Heart Valves: a Meta-Analysis
    Srivastava, Yeju
    Almader-Douglas, Diana
    Deo, Salil
    Sharma, Umesh
    NEUROLOGY, 2023, 100 (17)
  • [44] Factors determining the use of NOACs vs. Warfarin in a Kenyan cohort of patients requiring anticoagulation
    Mucyo, W.
    Jeilan, M.
    Varwani, M. H.
    Ngunga, M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2713 - 2713
  • [45] Comparative Effectiveness and Safety of New Oral Anticoagulants (NOACs) and Warfarin in Patients with Atrial Fibrillation: A Multi-Database Study in the US and UK
    Ali, M. Sanni
    van den Ham, Rianne
    Groenwold, Rolf H. H.
    Ankarfeldt, Mikkel Z.
    Adalsteinsson, Erpur
    Girman, Cynthia
    Klungel, Olaf H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 498 - 499
  • [46] Thrombophilias and new oral anticoagulants, a safe alternative to warfarin?
    Pizzi, G.
    Cotruzzola, A. M.
    Battaglia, V.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 569 - 570
  • [47] New Oral Anticoagulants: Should They Replace Heparins and Warfarin?
    Tsiara, Stavroula
    Pappas, Konstantinos
    Boutsis, Dimitrios
    Laffan, Mike
    HELLENIC JOURNAL OF CARDIOLOGY, 2011, 52 (01) : 52 - 67
  • [48] Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Elfar, Sohil
    Elzeiny, Sara Mohamed
    Ismail, Hesham
    Makkeyah, Yahya
    Ibrahim, Mokhtar
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [49] Direct Oral Anticoagulants vs. Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study
    Stanilova, Katerina
    Tijani, AminatA.
    Coons, Eric M.
    Casey, Ashley
    Mizuki, Britta
    Dermady, Miranda
    Bamnolker, Adi
    Alqudsi, Muhannad
    Velez, Juan Carlos Q.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 799 - 799
  • [50] Target-Specific Oral Anticoagulants: Should We Switch from Warfarin?
    Safavi-Naeini, Payam
    Saeed, Mohammad
    TEXAS HEART INSTITUTE JOURNAL, 2015, 42 (03) : 229 - 233
12345